LLY Eli Lilly and Co
- 803.170
- +19.990+2.55%
- 805.205
- +2.035+0.25%
Eli Lilly and Co News
JPM Lists Stocks With the Least Price Swings, Most Attractive Option-sale Candidates
Eli Lilly and Co Options Spot-On: On May 21st, 61,424 Contracts Were Traded, With 236.98K Open Interest
On May 21st ET, $Eli Lilly and Co(LLY.US)$ had active options trading, with a total trading volume of 61,424 options for the day, of which put options accounted for 26.44% of the total transactions, a
Form 144 | Eli Lilly and Co(LLY.US) 10% Stockholder Proposes to Sell 195.8 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 21, $Eli Lilly and Co(LLY.US)$ 10% Stockholder LILLY ENDOWMENT INC intends to sell 250K shares of its common stock on May 21, with a total market value of approximately $19
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
On Tuesday, Nestlé SA (OTC:NSRGF) (OTC:NSRGY) unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss medications and aid consumers focused on weight management. This com
Study Finds 30% of Wegovy, Saxenda Users Quit Within 4 Weeks
Eli Lilly's Stock on Pace for Record Close as Crohn's Disease Trial Hits the Mark
By Eleanor Laise Drugmaker also set to collaborate on new cancer treatments Eli Lilly & Co. (LLY) shares were on pace for a record closing high Tuesday after the drugmaker released data from a late-
Novo Nordisk Unsure When It Will Meet Obesity Drug Demand: Report
Express News | Novo Nordisk CEO, On Lilly's Diabetes Drug Approval In China, Says "It's One More Market Where There Will Be Two Critical Contenders Competing"; "Supplying All We Can", There Is No Drug Shortage Of Our Type 2 Diabetes Drug Ozempic In The U.S. Market;...
Express News | Lilly Shares Are Trading Higher After the Company's Tirzepatide Was Cleared for Diabetes in China
Eli Lilly on Track for Record High Close -- Data Talk
Eli Lilly and Company (LLY) is currently at $806.15, up $22.97 or 2.93% --Would be new all-time high (Based on available data back to July 18, 1972) --Would be first new all-time record closing high
Express News | Eli Lilly Shares up 3% After Co's Diabetes Drug Gets Approval in China
LLY.US (LLY.US) and Aktis Oncology signed a radiopharmaceutical cooperation agreement worth up to $1.1 billion
On Tuesday, private biotech company Aktis Oncology announced a partnership agreement with Eli Lilly to develop radiopharmaceuticals for cancer. The deal is worth up to $1.1 billion in terms of milestone payments alone.
Express News | Eli Lilly Shares Hit Record-High, Last up 4.3%
Microcap Mangoceuticals Doubles on Plan to Sell Cheap Oral GLP-1 Weight Loss Meds
Dow futures depreciate slightly, NVIDIA and minutes awaiting minutes = US stocks
Dow futures, S&P 500, and NASDAQ 100 have all been trending slightly lower in the US stock index futures market. Ahead of tomorrow's NVIDIA financial results and FOMC minutes, it seems that the atmosphere of wait-and-see is getting stronger in the US stock market.
Sector Update: Health Care Stocks Steady Premarket Tuesday
Health care stocks were steady premarket Tuesday, with the the Health Care Select Sector SPDR Fund (XLV) was down a slight 0.1% and the iShares Biotechnology ETF (IBB) recently unchanged. Larimar Ther
Eli Lilly Reports More Than 50% Remission Rate in Crohn's Treatment Trial
Eli Lilly reports that more than half of Crohn's disease patients achieved clinical remission after a year of treatment with mirikizumab in a recent trial.
Express News | Alloy Therapeutics: Licensing Agreement for Its Murine Platforms for Fully Human Antibody Discovery With Eli Lilly and Company
Express News | More Than One-Half of Patients With Crohn's Disease Treated With Lilly's Mirikizumab Achieved Clinical Remission at One Year, Including Patients With Previous Biologic Failure
Express News | Alloy Therapeutics Announces Platform License Agreement With Lilly
Analysis
Price Target
No Data
